文献速递生殖医学

个体化黄体期支持可恢复正常化活产率:人工子宫内膜准备周期中胚胎移植日孕酮水平低者

Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles.
PubMed 文献 · Fertil Steril · 2021-09-20

回顾性队列研究纳入2275例人工子宫内膜准备周期中囊胚移植日检测血清孕酮的患者,低孕酮(<9.2 ng/mL)者接受个体化黄体期支持(iLPS,每日皮下注射25 mg孕酮+标准阴道微粒化孕酮)。iLPS组活产率44.9%,与正常孕酮组45.0%无差异;校正混杂因素后低孕酮不影响活产率(调整OR 0.99,95%CI 0.79-1.25)。

要点

  • 移植日血清孕酮<9.2 ng/mL者接受iLPS后活产率与孕酮正常者相当(44.9% vs 45.0%)。
  • iLPS组活产率显著高于历史低孕酮未接受iLPS组(44.9% vs 37.3%;OR 1.37,95%CI 1.06-1.78)。
  • 低孕酮患者略年轻、BMI较高、增殖期雌二醇和孕酮较低,但仅BMI和雌二醇在多元分析中仍显著。

核心结论

  • 对血清孕酮水平低的患者实施个体化黄体期支持可获得与孕酮水平正常者相似的活产率。

研究设计与样本

  • 回顾性队列研究,2018年12月1日至2019年5月30日,私立医疗中心,共分析2275例囊胚移植日检测血清孕酮的患者。

主要发现

  • iLPS组活产率44.9%,正常孕酮组45.0%(粗OR 1.0,95%CI 0.82-1.22)。
  • 校正年龄、卵母细胞来源、鲜胚/冻胚、移植日、胚胎质量、移植胚胎数后,低孕酮不影响活产率(调整OR 0.99,95%CI 0.79-1.25)。
  • iLPS组活产率显著高于历史低孕酮未接受iLPS组(44.9% vs 37.3%;OR 1.37,95%CI 1.06-1.78)。
  • 两组其他妊娠结局无差异。
  • 低孕酮患者略年轻、BMI较高、增殖期雌二醇和孕酮较低;多元分析后仅BMI和雌二醇仍显著。

关键数值与推荐

  • 血清孕酮低定义为<9.2 ng/mL。
  • iLPS方案:自胚胎移植日起每日皮下注射25 mg孕酮,联合标准黄体期支持(阴道微粒化孕酮400 mg每日两次)。
  • 所有患者均接受阴道微粒化孕酮黄体期支持。

临床怎么用

  • 人工子宫内膜准备周期中,移植日检测血清孕酮,对<9.2 ng/mL者考虑个体化黄体期支持(每日皮下注射25 mg孕酮联合标准阴道孕酮)。
  • 该策略可使低孕酮患者的活产率恢复至与孕酮正常者相当的水平。

局限性

  • 回顾性队列研究,历史对照组非同期,可能存在时间偏倚。
  • 单中心私立医疗中心数据,外推性需谨慎。
  • 未报告样本量计算或效能分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the impact on live birth rates (LBRs) of the individualized luteal phase support (termed iLPS) in patients with low serum progesterone (P) levels compared with patients without iLPS. DESIGN: Retrospective cohort study, December 1, 2018, to May 30, 2019. SETTING: Private medical center. PATIENT(S): A total of 2,275 patients checked for serum P on the day of blastocyst transfer were analyzed. During the study period, 1,299 patients showed serum P levels of ≥9.2 ng/mL, whereas 550 showed serum P levels of <9.2 ng/mL and received iLPS. Additionally, a historical group of 426 patients with serum P levels of <9.2 ng/mL but no iLPS were used for comparison. Eligible patients were aged ≤50 years with adequate endometrium morphology after receiving estrogens. Luteal phase support was provided with micronized vaginal P (MVP) to all women. Patients with personalized initiation of exogenous P according to the endometrial receptivity assay test, polyps, fibroids distorting the cavity, or hydrosalpinx were not included in the analysis. INTERVENTION(S): As routine practice since December 2018, patients with low serum P levels received an iLPS with a daily injection of 25 mg of subcutaneous P from the day of embryo transfer (ET) in addition to standard LPS (400 mg of MVP twice a day). MAIN OUTCOME MEASURE(S): Live birth rate. RESULT(S): The LBR was 44.9% in the iLPS cases vs. 45.0% in patients with normal serum P levels (crude odds ratio [OR], 1.0; 95% confidence interval [CI], 0.82-1.22). By regression analysis, low serum P levels did not affect the LBR after adjusting for possible confounders (age, oocyte origin, fresh vs. frozen, day of ET, embryo quality, number of embryos transferred) (adjusted OR, 0.99; 95% CI, 0.79-1.25). Similarly, no differences were observed in other pregnancy outcomes between groups. The LBR was significantly higher in the group of patients who received additional subcutaneous P (iLPS) compared with the historical group with low serum P levels and no iLPS (44.9% vs. 37.3%; OR, 1.37; 95% CI, 1.06-1.78). In the overall population, patients showing P levels of <9.2 ng/mL on the day of ET were slightly younger and had higher body mass index and lower estradiol and P levels during the proliferative phase compared with patients with P levels of ≥9.2 ng/mL. No differences were observed with regard to the time in between the last dose of MVP and the serum P determination. After a multivariable logistic regression analysis, only body mass index and estradiol levels in the proliferative phase reminded statistically significant. Significant differences in the LBR were observed between patients with serum P levels of <9.2 ng/mL without iLPS and patients with serum P levels of ≥9.2 ng/mL when using either own or donated oocytes. CONCLUSION(S): Individualized LPS for patients with low serum P levels produces LBRs similar to those of patients with adequate serum P levels.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Labarta E, Mariani G, Rodríguez-Varela C, et al. Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles. Fertil Steril. 2021. PMID: 34548167. doi:10.1016/j.fertnstert.2021.08.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。